Literature DB >> 36045149

Primary aldosteronism - a multidimensional syndrome.

Adina F Turcu1, Jun Yang2,3, Anand Vaidya4.   

Abstract

Primary aldosteronism is a common cause of hypertension and is a risk factor for cardiovascular and renal morbidity and mortality, via mechanisms mediated by both hypertension and direct insults to target organs. Despite its high prevalence and associated complications, primary aldosteronism remains largely under-recognized, with less than 2% of people in at-risk populations ever tested. Fundamental progress made over the past decade has transformed our understanding of the pathogenesis of primary aldosteronism and of its clinical phenotypes. The dichotomous paradigm of primary aldosteronism diagnosis and subtyping is being redefined into a multidimensional spectrum of disease, which spans subclinical stages to florid primary aldosteronism, and from single-focal or multifocal to diffuse aldosterone-producing areas, which can affect one or both adrenal glands. This Review discusses how redefining the primary aldosteronism syndrome as a multidimensional spectrum will affect the approach to the diagnosis and subtyping of primary aldosteronism.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36045149     DOI: 10.1038/s41574-022-00730-2

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   47.564


  219 in total

1.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

Review 2.  Aldosterone paradox: differential regulation of ion transport in distal nephron.

Authors:  Juan Pablo Arroyo; Caroline Ronzaud; Dagmara Lagnaz; Olivier Staub; Gerardo Gamba
Journal:  Physiology (Bethesda)       Date:  2011-04

Review 3.  Pathogenesis and treatment of primary aldosteronism.

Authors:  Maria-Christina Zennaro; Sheerazed Boulkroun; Fabio L Fernandes-Rosa
Journal:  Nat Rev Endocrinol       Date:  2020-07-28       Impact factor: 43.330

Review 4.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 5.  High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It.

Authors:  Taweesak Wannachalee; Leedor Lieberman; Adina F Turcu
Journal:  Curr Hypertens Rep       Date:  2022-02-14       Impact factor: 5.369

6.  Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic Resonance.

Authors:  Alban Redheuil; Anne Blanchard; Helena Pereira; Zainab Raissouni; Aurelien Lorthioir; Gilles Soulat; Rosa Vargas-Poussou; Laurence Amar; Jean-Louis Paul; Dominique Helley; Michel Azizi; Nadjia Kachenoura; Elie Mousseaux
Journal:  JACC Cardiovasc Imaging       Date:  2020-09-16

7.  Screening for membrane hormone receptor expression in primary aldosteronism.

Authors:  O Zwermann; Y Suttmann; M Bidlingmaier; F Beuschlein; M Reincke
Journal:  Eur J Endocrinol       Date:  2009-01-08       Impact factor: 6.664

Review 8.  Regulation of Potassium Homeostasis.

Authors:  Biff F Palmer
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

Review 9.  Emergence and evolution of the renin-angiotensin-aldosterone system.

Authors:  David Fournier; Friedrich C Luft; Michael Bader; Detlev Ganten; Miguel A Andrade-Navarro
Journal:  J Mol Med (Berl)       Date:  2012-04-14       Impact factor: 4.599

10.  Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism.

Authors:  Matthieu St-Jean; Isabelle Bourdeau; Marc Martin; André Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.